Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Sofia Paul"'
Autor:
Stéphane de Botton, Thomas Cluzeau, Carlos Vigil, Rachel Cook, Philippe Rousselot, David Rizzieri, Jane Liesveld, Pierre Fenaux, Thorsten Braun, Arnaud Pigneux, Pierre Peterlin, Sofia Paul, Nisha Rajagopal, John Carulli, David Roth, Angela Volkert, Tanya Abdul Malak, Michael Kelly, Virginia Klimek, Eytan Stein
Publikováno v:
HemaSphere, Vol 7, p e50253dc (2023)
Externí odkaz:
https://doaj.org/article/657eb274071c45c3bfd53fbd8fe48262
Autor:
Stéphane de Botton, Thomas Cluzeau, Carlos Vigil, Rachel J. Cook, Philippe Rousselot, David A. Rizzieri, Jane L. Liesveld, Pierre Fenaux, Thorsten Braun, Anne Banos, Joseph G. Jurcic, Mikkael A. Sekeres, Michael R. Savona, Gail J. Roboz, Dale Bixby, Kate Madigan, Angela Volkert, Kristin Stephens, Qing Kang-Fortner, Kristen Baker, Sofia Paul, Michael McKeown, John Carulli, Matthew Eaton, Graeme Hodgson, Christopher Fiore, Michael J. Kelly, David A. Roth, Eytan M. Stein
Publikováno v:
Blood Advances. 7:1858-1870
A superenhancer at the retinoic acid receptor alpha (RARA) gene is associated with RARA mRNA overexpression in ∼30% of non-acute promyelocytic leukemia acute myeloid leukemia (AML) and in ∼50% of myelodysplastic syndromes (MDS). RARA overexpressi
Autor:
Manish Sharma, Babar Bashir, Dejan Juric, Erika P. Hamilton, Kyriakos P. Papadopoulos, Susanna Varkey Ulahannan, Geoffrey Shapiro, Vaibhav Sahai, Niharika B. Mettu, Monica M. Mita, Mehmet Akce, Jessica Tao, Graeme Hodgson, Nan Ke, Susan Henry, Sofia Paul, Neha Lodaya, Catherine Madigan, David A. Roth, Virginia Klimek
Publikováno v:
Journal of Clinical Oncology. 40:TPS4180-TPS4180
TPS4180 Background: SY-5609 is an oral, selective, potent CDK7 inhibitor that targets two fundamental processes in cancer: transcription and cell cycle control. Early results from the Phase 1 dose escalation portion in patients (pts) with advanced so
Autor:
Daniel Väisänen, Peter J. Johansson, Lena Kallings, Erik Hemmingsson, Gunnar Andersson, Peter Wallin, Sofia Paulsson, Teresia Nyman, Andreas Stenling, Magnus Svartengren, Elin Ekblom-Bak
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Sickness absence from work has a large adverse impact on both individuals and societies in Sweden and the costs for sickness absence were calculated to 64.6 billion Swedish kronor (approx. 5.6 billion in Euros) in 2020. Although high cardior
Externí odkaz:
https://doaj.org/article/b776748385cb4f3d9b6dc013dab700f9
Autor:
Beata Holkova, Hang Quach, Christoph M. Ahlers, Nicola Jackson, Brandon E. Kremer, Niels W.C.J. van de Donk, Katja Weisel, Maria Brouch, Suzanne Trudel, Ellie Im, Sofia Paul, Paul G. Richardson, Rocio Montes de Oca, Shinta Cheng, Paula Rodriguez Otero, Geraldine Ferron-Brady, Kevin W. Song, L Smith, Monique C. Minnema, Ajay K. Nooka, David Routledge, Ira Gupta, Natalie S. Callander, Nahi Hareth
Publikováno v:
Future oncology (London, England). 17(16)
Belantamab mafodotin (belamaf) is a BCMA-targeted antibody–drug conjugate recently approved as monotherapy for adults with relapsed/refractory multiple myeloma who have received ≥4 prior therapies. Belamaf binds to BCMA and eliminates myeloma cel
Autor:
Larry D. Anderson, Cristina Gasparetto, Faiz Anwer, Stephanie Petrone, Eric Lewis, Mehmet H. Kocoglu, Eben I. Lichtman, Malin Hultcrantz, Jonathan L. Kaufman, Hong Li, Ruben Niesvizky, Sofia Paul, Clifton C. Mo
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S439-S440
Context The belamaf US EAP (NCT03763370) provided medicine access to patients unable to participate in a clinical trial prior to regulatory agency approval. Objective To obtain insight from the belamaf EAP on patient types potentially eligible for be
Autor:
Malin Hultcrantz, Larry D. Anderson, Faiz Anwer, Cristina Gasparetto, Mehmet H. Kocoglu, Eben I. Lichtman, Clifton Mo, Ruben Niesvizky, Eric Lewis, Hong Li, Sofia Paul, Stephanie Petrone, Jonathan L. Kaufman
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S252
Autor:
Anne Yeakey, Paul G. Richardson, Chris Shelton, David Routledge, Ajay K. Nooka, Hareth Nahi, Suzanne Trudel, Hang Quach, Brandon E. Kremer, Kevin W. Song, Rocio Montes de Oca, Elaine M. Paul, Josephine Khan, Paula Rodriguez-Otero, Beata Holkova, Sofia Paul, Maria Brouch, Geraldine Ferron-Brady, Ira Gupta, Ellie Im, L. Mary Smith, Christoph M. Ahlers
Publikováno v:
Blood. 136:1-2
Introduction: Single-agent belamaf (GSK2857916), a B-cell maturation antigen-targeting antibody-drug conjugate, induced deep and durable responses in patients with RRMM, with a manageable safety profile with 13 months of follow-up (DREAMM-2; NCT03525
Autor:
Philippe Moreau, Sung-Soo Yoon, Noppadol Siritanaratkul, Thanyaphong Na Nakorn, Jian Hou, Suman Redhu, Meral Beksac, Vania Hungria, Robert L. Schlossman, Paul G. Richardson, Jesús F. San-Miguel, Jae Hoon Lee, Andreas Guenther, Claudia Corrado, Wiesław Wiktor Jędrzejczak, Sofia Paul, Sagar Lonial, Meletios A. Dimopoulos, Hans Salwender, Monika Sopala, Hermann Einsele, Ashraf Elghandour
Publikováno v:
British Journal of Haematology. 179:66-74
Panobinostat in combination with bortezomib and dexamethasone demonstrated a significant and clinically meaningful progression-free survival benefit compared with placebo, bortezomib and dexamethasone in the phase 3 PANORAMA 1 (Panobinostat Oral in M
Autor:
Amanda Lönn, Lena V. Kallings, Gunnar Andersson, Sofia Paulsson, Peter Wallin, Jane Salier Eriksson, Elin Ekblom-Bak
Publikováno v:
International Journal of Behavioral Nutrition and Physical Activity, Vol 20, Iss 1, Pp 1-12 (2023)
Abstract Background Healthy lifestyle habits are recommended in prevention of cardiovascular disease (CVD). However, there is limited knowledge concerning the change in lifestyle-related factors from before to after a CVD event. Thus, this study aime
Externí odkaz:
https://doaj.org/article/bba34410c87042599d50851816a8f0f5